Tetraneuron Touts Its Multifactorial Gene Therapy Solution For Alzheimer’s
Spanish Biotech Close To Clinic
Executive Summary
Emerging Company Profile: The biotech plans to enter the clinic next year with a gene therapy targeting the E2F4 protein in the hopes of halting Alzheimer’s disease progression and restoring lost function.